Primum non nocere: allo-HSCT for AML in CR1
Blood
.
2021 Jan 28;137(4):438-439.
doi: 10.1182/blood.2020008641.
Authors
Roni Shouval
1
,
Robert J Soiffer
2
Affiliations
1
Memorial Sloan Kettering Cancer Center.
2
Dana-Farber Cancer Institute.
PMID:
33507303
DOI:
10.1182/blood.2020008641
No abstract available
Publication types
Comment
MeSH terms
Adult
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / therapy
Receptors, Complement 3b
Substances
CR1 protein, human
Receptors, Complement 3b